Evidence map›Paper›PMID 25337776›Full record

ArticleKidney international2015

Experimental coronary artery stenosis accelerates kidney damage in renovascular hypertensive swine.

Dong Sun, Alfonso Eirin, Xiang-Yang Zhu, Xin Zhang, John A Crane, John R Woollard, Amir Lerman, Lilach O Lerman

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Kidney international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03321942 (The Biological Characteristics of Adipose Tissue-derived Mesenchymal Stem Cells and Its Role in the Treatment of Chronic Renal Failure), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03321942 naunknown statusnot on this mapstarted 2017, after this paper: background citation

The Biological Characteristics of Adipose Tissue-derived Mesenchymal Stem Cells and Its Role in the Treatment of Chronic Renal Failure

TypeinterventionalSponsorThe Affiliated Hospital of Xuzhou Medical UniversityRan2017 to 2018Enrolled100ConditionsMesenchymal Stem Cells, Chronic Kidney Diseases, Renal Interstitial FibrosisArmsTreatment group, Control group
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Review
  3. SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease.Oxidative medicine and cellular longevity · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Dong Sun1] Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA [2] Department of Nephrology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, China.
Alfonso EirinDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Xiang-Yang ZhuDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Xin ZhangDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
John A CraneDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
John R WoollardDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Amir LermanDivision Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA.
Lilach O Lerman1] Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA [2] Division Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA.
Mayo Clinic · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
CT imaging for the assessment of kidney injury distal to renal artery stenosisR01DK073608 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2006 to 2015
$3.1M
Hypoxia and inflammatory injury in human renovascular hypertensionR01DK100081 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O, TEXTOR, STEPHEN C · 2014 to 2018
$2.8M
CT Evaluation of the Myocardial Effects of Risk FactorsR01HL077131 · NHLBI · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2004 to 2013
$2.8M
EXTRAMURAL RES FACIL IMPROVEMENT PROG: POLYCYSTIC KIDNEY DISEASE, RENAL STUDIES,C06RR018898 · NCRR · MAYO CLINIC · PI BURNETT, JOHN C · 2004 to 2004
$2.3M
Lp-PLA2 and Coronary Atherosclerosis in HumansR01HL092954 · NHLBI · MAYO CLINIC ROCHESTER · PI LERMAN, AMIR · 2009 to 2013
$2.1M
Role of Endothelial Progenitor Cells in vascular Aging and CalcificationR01AG031750 · NIA · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP, LERMAN, AMIR · 2010 to 2014
$2.0M
Low-Energy Shockwave Treatment Distal To Peripheral Vascular DiseaseR21HL121561 · NHLBI · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2014 to 2015
$434k
NCATS NIH HHS UL1 TR000135NCRR NIH HHS C06 RR018898NCRR NIH HHS C06-RR018898NHLBI NIH HHS HL121561NHLBI NIH HHS HL77131NHLBI NIH HHS HL-92954NHLBI NIH HHS R01 HL077131NHLBI NIH HHS R01 HL092954NHLBI NIH HHS R21 HL121561NIA NIH HHS AG-31750NIA NIH HHS R01 AG031750NIDDK NIH HHS DK100081NIDDK NIH HHS DK73608NIDDK NIH HHS R01 DK073608NIDDK NIH HHS R01 DK100081
6 · The paper itself

Abstract

The impact of coronary artery stenosis (CAS) on renal injury is unknown. Here we tested whether the existence of CAS, regardless of concurrent atherosclerosis, would induce kidney injury and magnify its susceptibility to damage from coexisting hypertension (HT). Pigs (seven each) were assigned to sham, left-circumflex CAS, renovascular HT, and CAS plus HT groups. Cardiac and nonstenotic kidney functions, circulating and renal inflammatory and oxidative markers, and renal and microvascular remodeling were assessed 10 weeks later. Myocardial perfusion declined distal to CAS. Systemic levels of PGF2-α isoprostane, a marker of oxidative stress, increased in CAS and CAS plus HT, whereas single-kidney blood flow responses to acetylcholine were significantly blunted only in CAS plus HT compared with sham, HT, and CAS, indicating renovascular endothelial dysfunction. Tissue expression of inflammatory and oxidative markers were elevated in the CAS pig kidney, and further magnified in CAS plus HT, whereas angiogenic factor expression was decreased. Bendavia, a mitochondria-targeted peptide, decreased oxidative stress and improved renal function and structure in CAS. Furthermore, CAS and HT synergistically amplified glomerulosclerosis and renal fibrosis. Thus, mild myocardial ischemia, independent of systemic atherosclerosis, induced renal injury, possibly mediated by increased oxidative stress. Superimposed HT aggravates renal inflammation and endothelial dysfunction caused by CAS, and synergistically promotes kidney fibrosis, providing impetus to preserve cardiac integrity in order to protect the kidney.

Indexed as

AcetylcholineAcute Kidney InjuryAnimalsAntioxidantsArterial PressureCoronary AngiographyCoronary StenosisCoronary VesselsDinoprostEndotheliumFemaleFibrosisGlomerular Filtration RateHypertension, RenovascularKidneyOligopeptidesAcetylcholineAntioxidantsarginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamideDinoprostOligopeptidesTransforming Growth Factor beta1

Identifiers

PMID25337776
PMCPMC4382395
OpenAlexW1993951002

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.